Discovery is the key to advancing human health. Find out how our leading researchers are pioneering new, breakthrough solutions to some of the world’s most challenging health problems.
The study led by Hira Mian, will look at remote treatment and care for adult patients with multiple myeloma, to improve patient care and reduce pressure on Canada’s health systems.
The $2.2-million drug discovery partnership with the B.C.-based biotech company will explore using diverse fungi for medicinal purposes, and will facilitate the large-scale production of any leads.
Led by CEO John Valliant, the company that develops next-generation precision cancer medicines will become a wholly owned subsidiary of AstraZeneca and continue its operations at its state-of-the-art facility at McMaster Innovation Park.
McMaster logo
